Skip to main content

Articles

Page 45 of 65

  1. The extracellular matrix (ECM) has a key role in facilitating the progression of ovarian cancer and we have shown recently that the secreted ECM protein TGFBI modulates the response of ovarian cancer to paclit...

    Authors: David A Tumbarello, Jillian Temple and James D Brenton
    Citation: Molecular Cancer 2012 11:36
  2. Increased consumption of plant-based diets has been linked to the presence of certain phytochemicals, including polyphenols such as flavonoids. Several of these compounds exert their protective effect via inhi...

    Authors: Sofia Bellou, Evdoxia Karali, Eleni Bagli, Nawaf Al-Maharik, Lucia Morbidelli, Marina Ziche, Herman Adlercreutz, Carol Murphy and Theodore Fotsis
    Citation: Molecular Cancer 2012 11:35
  3. 2,4-Dimethoxyphenyl-E-4-arylidene-3-isochromanone (IK11) was previously described to induce apoptotic death of A431 tumor cells. In this report, we investigated the molecular action of IK11 in the HepG2 human hep...

    Authors: Balazs Radnai, Csenge Antus, Boglarka Racz, Peter Engelmann, Janos Krisztian Priber, Zsuzsanna Tucsek, Balazs Veres, Zsuzsanna Turi, Tamas Lorand, Balazs Sumegi and Ferenc Gallyas Jr
    Citation: Molecular Cancer 2012 11:34
  4. Toll-like receptor 4 (TLR4) is expressed on immune cells as a sensor that recognizes lipopolysaccharide (LPS), a microbial conserved component. It has recently been determined that the expression of TLR4 is al...

    Authors: Zujun Sun, Qingqiong Luo, Dongxia Ye, Wantao Chen and Fuxiang Chen
    Citation: Molecular Cancer 2012 11:33
  5. High-grade gliomas, including glioblastomas (GBMs), are recalcitrant to local therapy in part because of their ability to invade the normal brain parenchyma surrounding these tumors. Animal models capable of r...

    Authors: L Gerard Toussaint III, Allan E Nilson, Jennie M Goble, Karla V Ballman, C David James, Florence Lefranc, Robert Kiss and Joon H Uhm
    Citation: Molecular Cancer 2012 11:32
  6. Hepatocellular carcinoma (HCC) has a dismal 5-year-survival rate of 10%, so novel strategies are warranted. IL-24 mediates anti-tumor activity reducing STAT3 expression, which suggests that interferon (IFN) al...

    Authors: Cong-Jun Wang, Chao-Wen Xiao, Tian-Geng You, Ya-Xin Zheng, Wei Gao, Zhu-Qing Zhou, Jun Chen, Xin-Bo Xue, Jia Fan and Hui Zhang
    Citation: Molecular Cancer 2012 11:31
  7. Induction of osteoblast differentiation by paracrine Sonic hedgehog (Shh) signaling may be a mechanism through which Shh-expressing prostate cancer cells initiate changes in the bone microenvironment and promo...

    Authors: Samantha M Zunich, Maria Valdovinos, Taneka Douglas, David Walterhouse, Philip Iannaccone and Marilyn L G Lamm
    Citation: Molecular Cancer 2012 11:30
  8. CADM1 encodes an immunoglobulin superfamily (IGSF) cell adhesion molecule. Inactivation of CADM1, either by promoter hypermethylation or loss of heterozygosity, has been reported in a wide variety of tumor types,...

    Authors: Louise van der Weyden, Mark J Arends, Alistair G Rust, George Poulogiannis, Rebecca E McIntyre and David J Adams
    Citation: Molecular Cancer 2012 11:29
  9. Cellular senescence represents a tumor suppressive response to a variety of aberrant and oncogenic insults. We have previously described a transgenic mouse model of Cyclin D1-driven senescence in pineal cells ...

    Authors: Hasan Zalzali, Mohamad Harajly, Lina Abdul-Latif, Nader El-Chaar, Ghassan Dbaibo, Stephen X Skapek and Raya Saab
    Citation: Molecular Cancer 2012 11:28
  10. Platinum compounds such as cisplatin and carboplatin are DNA crosslinking agents widely used for cancer chemotherapy. However, the effectiveness of platinum compounds is often tempered by the acquisition of ce...

    Authors: Céline Jacquemont, Julian A Simon, Alan D D'Andrea and Toshiyasu Taniguchi
    Citation: Molecular Cancer 2012 11:26
  11. Metastatic melanoma is a lethal skin cancer and its incidence is rising every year. It represents a challenge for oncologist, as the current treatment options are non-curative in the majority of cases; therefo...

    Authors: Aitziber Buqué, Jangi Sh Muhialdin, Alberto Muñoz, Begoña Calvo, Sergio Carrera, Unai Aresti, Aintzane Sancho, Itziar Rubio and Guillermo López-Vivanco
    Citation: Molecular Cancer 2012 11:25
  12. The membrane-bound mucins are thought to play an important biological role in cell–cell and cell–matrix interactions, in cell signaling and in modulating biological properties of cancer cell. MUC4, a transmemb...

    Authors: Sateesh Kunigal, Moorthy P Ponnusamy, Navneet Momi, Surinder K Batra and Srikumar P Chellappan
    Citation: Molecular Cancer 2012 11:24
  13. MicroRNAs (miRNAs) have been suggested to play a vital role in tumor initiation and progression by negatively regulating oncogenes and tumor suppressors. Quite recently, studies have identified some miRNAs ope...

    Authors: Yu Zhang, Zhongqiu Wang, Min Chen, Liang Peng, Xinying Wang, Qunying Ma, Fengli Ma and Bo Jiang
    Citation: Molecular Cancer 2012 11:23
  14. TAK733 is a novel allosteric, non-ATP-binding, inhibitor of the BRAF substrates MEK-1/2.

    Authors: Erika von Euw, Mohammad Atefi, Narsis Attar, Connie Chu, Sybil Zachariah, Barry L Burgess, Stephen Mok, Charles Ng, Deborah JL Wong, Bartosz Chmielowski, David I Lichter, Richard C Koya, Tara A McCannel, Elena Izmailova and Antoni Ribas
    Citation: Molecular Cancer 2012 11:22
  15. Interferon Regulatory Factor 5 is a transcription factor that regulates the expression of genes involved in the response to viral infection and in the stimulation of the immune system. Moreover, multiple studi...

    Authors: Michele Massimino, Paolo Vigneri, Manuela Fallica, Annamaria Fidilio, Alessandra Aloisi, Francesco Frasca and Livia Manzella
    Citation: Molecular Cancer 2012 11:21
  16. The current treatment regimen for glioma patients is surgery, followed by radiation therapy plus temozolomide (TMZ), followed by 6 months of adjuvant TMZ. Despite this aggressive treatment regimen, the overall...

    Authors: Chad R Schultz, William A Golembieski, Daniel A King, Stephen L Brown, Chaya Brodie and Sandra A Rempel
    Citation: Molecular Cancer 2012 11:20
  17. We have identified syndecan-2 as a protein potentially involved in perineural invasion of pancreatic adenocarcinoma (PDAC) cells.

    Authors: Tiago De Oliveira, Ivane Abiatari, Susanne Raulefs, Danguole Sauliunaite, Mert Erkan, Bo Kong, Helmut Friess, Christoph W Michalski and Jörg Kleeff
    Citation: Molecular Cancer 2012 11:19
  18. HLTF (Helicase-like Transcription Factor) is a DNA helicase protein homologous to the SWI/SNF family involved in the maintenance of genomic stability and the regulation of gene expression. HLTF has also been f...

    Authors: Sumit Sandhu, Xiaoli Wu, Zinnatun Nabi, Mojgan Rastegar, Sam Kung, Sabine Mai and Hao Ding
    Citation: Molecular Cancer 2012 11:18
  19. Cell cycle deregulation is common in human cancer, and alterations of p27 and p21, two critical cell cycle regulators, have been implicated in the development of many human malignancies. Therefore, we hypothesize...

    Authors: Zhongqiu Wang, Erich M Sturgis, Fenghua Zhang, Dapeng Lei, Zhensheng Liu, Li Xu, Xicheng Song, Qingyi Wei and Guojun Li
    Citation: Molecular Cancer 2012 11:17
  20. Chronic Myeloid Leukemia (CML) is a malignant pluripotent stem cells disorder of myeloid cells. In CML patients, polymorphonuclear leukocytes (PMNL) the terminally differentiated cells of myeloid series exhibi...

    Authors: Poonam R Molli, Madhura B Pradhan, Suresh H Advani and Nishigandha R Naik
    Citation: Molecular Cancer 2012 11:16
  21. The c-Myb transcription factor is essential for the maintenance of stem-progenitor cells in bone marrow, colon epithelia, and neurogenic niches. c-Myb malfunction contributes to several types of malignancies i...

    Authors: Lucia Knopfová, Petr Beneš, Lucie Pekarčíková, Markéta Hermanová, Michal Masařík, Zuzana Pernicová, Karel Souček and Jan Šmarda
    Citation: Molecular Cancer 2012 11:15
  22. We had previously demonstrated overexpression of fibroblast growth factor receptor-4 (FGFR4) in hepatocellular carcinoma (HCC). However, additional molecular mechanisms resulting in amplified FGFR4 signaling i...

    Authors: Weijie Poh, Winnie Wong, Huimin Ong, Myat Oo Aung, Seng Gee Lim, Boon Tin Chua and Han Kiat Ho
    Citation: Molecular Cancer 2012 11:14
  23. HuR, an RNA binding protein involved in the post-transcriptional regulation of a wide spectrum of mRNAs, has been demonstrated to be a determinant of carcinogenesis and tumor aggressiveness in several cancer t...

    Authors: Elisa Latorre, Toma Tebaldi, Gabriella Viero, Antonino Maria Spartà, Alessandro Quattrone and Alessandro Provenzani
    Citation: Molecular Cancer 2012 11:13
  24. The Signal Transducer and Activator of Transcription 3 (STAT3) is activated in tumor cells, and STAT3-inhibitors are able to induce the death of those cells. Decoy oligodeoxynucleotides (dODNs), which bind to ...

    Authors: Inès Souissi, Patrick Ladam, Jean AH Cognet, Stéphanie Le Coquil, Nadine Varin-Blank, Fanny Baran-Marszak, Valeri Metelev and Remi Fagard
    Citation: Molecular Cancer 2012 11:12
  25. Semaphorins act as chemotactic cues for cell movement via their transmembrane receptors, plexins. Somatic missense mutations in the plexinB1 gene coupled with overexpression of the protein frequently occur in ...

    Authors: Chun Zhou, Oscar Gee-Wan Wong, John R Masters and Magali Williamson
    Citation: Molecular Cancer 2012 11:11
  26. Hepatoblastoma (HB) is an embryonal liver neoplasm of early childhood with a poor prognosis for patients with distant metastases and vascular invasion. We and others have previously shown that the overexpressi...

    Authors: Ivonne Regel, Melanie Eichenmüller, Saskia Joppien, Johanna Liebl, Beate Häberle, Josef Müller-Höcker, Angelika Vollmar, Dietrich von Schweinitz and Roland Kappler
    Citation: Molecular Cancer 2012 11:9
  27. Acute myeloid leukaemia (AML) with nucleophosmin-1 (NPM1) mutation is a major subtype of AML. The NPM1 mutation induces a myeloproliferative disorder, but evidence indicates that other insults are necessary for t...

    Authors: Adam Bryant, Catalina A Palma, Vivek Jayaswal, Yee Wa Yang, Mark Lutherborrow and David DF Ma
    Citation: Molecular Cancer 2012 11:8
  28. Protein tyrosine phosphatase receptor delta (PTPRD) is a member of a large family of protein tyrosine phosphatases which negatively regulate tyrosine phosphorylation. Neuroblastoma is a major childhood cancer ...

    Authors: Maria Meehan, Laavanya Parthasarathi, Niamh Moran, Caroline A Jefferies, Niamh Foley, Elisa Lazzari, Derek Murphy, Jacqueline Ryan, Berenice Ortiz, Armida W M Fabius, Timothy A Chan and Raymond L Stallings
    Citation: Molecular Cancer 2012 11:6
  29. microRNAs have been established as powerful regulators of gene expression in normal physiological as well as in pathological conditions, including cancer progression and metastasis. Recent studies have demonst...

    Authors: Katarzyna Augoff, Brian McCue, Edward F Plow and Khalid Sossey-Alaoui
    Citation: Molecular Cancer 2012 11:5
  30. Although cigarette smoking is the principal cause of lung carcinogenesis, chronic obstructive pulmonary disease (COPD), an inflammatory disease of the lung, has been identified as an independent risk factor fo...

    Authors: Peter Barta, Carolyn Van Pelt, Taoyan Men, Burton F Dickey, Reuben Lotan and Seyed Javad Moghaddam
    Citation: Molecular Cancer 2012 11:4
  31. The receptor tyrosine kinase family includes many transmembrane proteins with diverse physiological and pathophysiological functions. The involvement of tyrosine kinase signaling in promoting a more aggressive...

    Authors: Aaron M Marshall, Rebecca J McClaine, Devikala Gurusamy, Jerilyn K Gray, Kara E Lewnard, Sohaib A Khan and Susan E Waltz
    Citation: Molecular Cancer 2012 11:2
  32. Colorectal carcinomas (CRC) carry massive genetic and transcriptional alterations that influence multiple cellular pathways. The study of proteins whose loss-of-function (LOF) alters the growth of CRC cells ca...

    Authors: Amanda B Hummon, Jason J Pitt, Jordi Camps, Georg Emons, Susan B Skube, Konrad Huppi, Tamara L Jones, Tim Beissbarth, Frank Kramer, Marian Grade, Michael J Difilippantonio, Thomas Ried and Natasha J Caplen
    Citation: Molecular Cancer 2012 11:1
  33. Bcl-3 is an established oncogene in hematologic malignancies, such as B-cell chronic lymphocytic leukemias. Nevertheless, recent research has shown that it also participates in progression of diverse solid tum...

    Authors: Vilma Maldonado and Jorge Melendez-Zajgla
    Citation: Molecular Cancer 2011 10:152
  34. Clinical studies have shown antineoplastic effectiveness of monoclonal antibodies (MAbs) against EGFR for different indications. Several MAbs directed to EGFR were developed recently, such as matuzumab, but th...

    Authors: Debora D Meira, Vitor H Almeida, Jânio S Mororó, Mauricio S Caetano, Isabel P Nóbrega, Delano Batista, Cinthya Sternberg and Carlos G Ferreira
    Citation: Molecular Cancer 2011 10:151
  35. The Th17 subset and IL-17 have been found in increased frequencies within certain tumors. However, their relevance in cancer biology remains controversial. This study aimed to clarify the biological action of ...

    Authors: Fang-Ming Gu, Quan-Lin Li, Qiang Gao, Jia-Hao Jiang, Kai Zhu, Xiao-Yong Huang, Jin-Feng Pan, Jun Yan, Jin-Hui Hu, Zheng Wang, Zhi Dai, Jia Fan and Jian Zhou
    Citation: Molecular Cancer 2011 10:150
  36. The adenomatous polyposis coli (APC) protein is part of the destruction complex controlling proteosomal degradation of β-catenin and limiting its nuclear translocation, which is thought to play a gate-keeping ...

    Authors: Kristoffer W Brudvik, Jan E Paulsen, Einar M Aandahl, Borghild Roald and Kjetil Taskén
    Citation: Molecular Cancer 2011 10:149
  37. Metastasis is the leading cause of death among breast cancer patients. Identifying key cellular factors controlling invasion and metastasis of breast cancer cells should pave the way to new therapeutic strateg...

    Authors: David Beauchemin, Catherine Lacombe and Céline Van Themsche
    Citation: Molecular Cancer 2011 10:148
  38. Proteolytic enzymes have been implicated in driving tumor progression by means of their cancer cell microenvironment activity where they promote proliferation, differentiation, apoptosis, migration, and invasi...

    Authors: Hang Fai Kwok, Richard J Buick, Diana Kuehn, Julie A Gormley, Declan Doherty, Thomas J Jaquin, Angela McClurg, Claire Ward, Teresa Byrne, Jacob Jaworski, Ka Lai Leung, Philip Snoddy, Christine McAnally, Roberta E Burden, Breena Gray, Jenny Lowry…
    Citation: Molecular Cancer 2011 10:147
  39. Smoking and stress, pancreatic cancer (PanCa) risk factors, stimulate nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and catecholamines production respectively. NNK and catecholamine bind the...

    Authors: Dong Zhang, Qingyong Ma, Zheng Wang, Min Zhang, Kun Guo, Fengfei Wang and Erxi Wu
    Citation: Molecular Cancer 2011 10:146
  40. YB-1 is a multifunctional protein that affects transcription, splicing, and translation. Overexpression of YB-1 in breast cancers causes cisplatin resistance. Recent data have shown that YB-1 is also overexpre...

    Authors: Serges P Tsofack, Chantal Garand, Chris Sereduk, Donald Chow, Meraj Aziz, David Guay, Hongwei H Yin and Michel Lebel
    Citation: Molecular Cancer 2011 10:145
  41. Fibroblast growth factors FGF-1 and FGF-2 are often upregulated in tumors, but tightly bound to heparan sulphate proteoglycans of the extracellular matrix (ECM). One mechanism of their bioactivation relies on ...

    Authors: Daniel Schulze, Philipp Plohmann, Sabrina Höbel and Achim Aigner
    Citation: Molecular Cancer 2011 10:144
  42. Gefitinib is a tyrosine kinase inhibitor (TKI) of the epidermal growth factor receptor (EGFR) especially effective in tumors with activating EGFR gene mutations while EGFR wild-type non small cell lung cancer ...

    Authors: Roberta R Alfieri, Maricla Galetti, Stefano Tramonti, Roberta Andreoli, Paola Mozzoni, Andrea Cavazzoni, Mara Bonelli, Claudia Fumarola, Silvia La Monica, Elena Galvani, Giuseppe De Palma, Antonio Mutti, Marco Mor, Marcello Tiseo, Ettore Mari, Andrea Ardizzoni…
    Citation: Molecular Cancer 2011 10:143
  43. Pancreatic ductal adenocarcinoma (PDAC) is known by its aggressiveness and lack of effective therapeutic options. Thus, improvement in current knowledge of molecular changes associated with pancreatic cancer i...

    Authors: Ana C Tahira, Márcia S Kubrusly, Michele F Faria, Bianca Dazzani, Rogério S Fonseca, Vinicius Maracaja-Coutinho, Sergio Verjovski-Almeida, Marcel CC Machado and Eduardo M Reis
    Citation: Molecular Cancer 2011 10:141
  44. Papillomaviruses (PVs) are established agents of human and animal cancers. They infect cutaneous and mucous epithelia. High Risk (HR) Human PVs (HPVs) are consistently associated with cancer of the uterine cer...

    Authors: Aldo Venuti, Francesca Paolini, Lubna Nasir, Annunziata Corteggio, Sante Roperto, Maria S Campo and Giuseppe Borzacchiello
    Citation: Molecular Cancer 2011 10:140
  45. Pancreas cancer is one of most aggressive human cancers with the survival rate for patients with metastatic pancreas cancer at 5-6 months. The poor survival demonstrates a clear need for better target identifi...

    Authors: Kevin Vo, Barushi Amarasinghe, Kay Washington, Adriana Gonzalez, Jordan Berlin and Thao P Dang
    Citation: Molecular Cancer 2011 10:138

Annual Journal Metrics

  • 2022 Citation Impact
    37.3 - 2-year Impact Factor
    33.1 - 5-year Impact Factor
    5.740 - SNIP (Source Normalized Impact per Paper)
    8.703 - SJR (SCImago Journal Rank)

    2023 Speed
    5 days submission to first editorial decision for all manuscripts (Median)
    91 days submission to accept (Median)

    2023 Usage 
    3,569,666 downloads
    2,070 Altmetric mentions